| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MT-ND4 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | EPM2AIP1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | FOS | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | TRIM7 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | KRTAP5-5 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | MYSM1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | GFER | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ITGA7 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | DGCR14 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | CNKSR2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
